dr. li discusses the profile crizotinib clinical trials
Published 12 years ago • 427 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:30
dr. li discusses alk gene mutation tests
-
0:36
dr. li describes the future of lung cancer therapy
-
0:54
dr. li discusses the eml4-alk fusion gene
-
1:53
dr. kris on the crizotinib clinical trials
-
1:22
dr. crinò on crizotinib in alk nsclc
-
1:05
dr. west discusses crizotinib in alk-nsclc trial results
-
1:27
dr. ou on the use of crizotinib in patients with ros1-rearranged nsclc
-
0:51
dr. tianhong (tina) li reviews the lux-lung 3 trial afatinib data
-
1:11
dr. salgia on crizotinib and other tkis in alk-positive nsclc
-
0:59
dr. kerrigan on design and findings of the profile 1001 trial in ros1-mutated nsclc
-
1:45
dr. shaw on using crizotinib to treat lung cancer
-
1:05
dr. andre goy on crizotinib for alk-positive pediatric patients with alcl
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
1:54
dr. shaw on monitoring crizotinib-related side effects
-
4:38
patterns of progression on crizotinib for alk nsclc
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
1:40
dr. langer discusses the jmen maintenance pemetrexed trial
-
12:46
alk lung cancer and crizotinib update
-
1:03
dr. mills gives examples of unexpected therapy responses